Once-Daily Subcutaneous Irisin Administration Mitigates Depression- and Anxiety-like Behavior in Young Mice

Once-Daily Subcutaneous Irisin Administration Mitigates Depression- and Anxiety-like Behavior in Young Mice

Major depression is one of the most common psychiatric disorders worldwide, usually associated with anxiety. The multi-etiological nature of depression has increased the search for new antidepressant molecules, including irisin, for which, in a previous study, we tested its effect in young mice when...

Full description

Bibliographic Details
Main Authors: Patrizia Pignataro, Manuela Dicarlo, Clelia Suriano, Lorenzo Sanesi, Roberta Zerlotin, Giuseppina Storlino, Angela Oranger, Chiara Zecca, Maria Teresa Dell’Abate, Giorgio Mori, Maria Grano, Silvia Colucci, Graziana Colaianni
Format: Article
Language:English
Published: MDPI AG 2023-04-01
Series:International Journal of Molecular Sciences
Subjects:
antidepressant
anxiolytic
irisin
subcutaneous injection
young mice
open field test
Online Access:https://www.mdpi.com/1422-0067/24/7/6715

Internet

https://www.mdpi.com/1422-0067/24/7/6715

Similar Items